Skin Microbiome, a Long Story of Clinical Trials 2.0
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 2870
Special Issue Editor
Interests: immunology; pharmacology; neurobiology; skin physiology; skin microbiome
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is the continuation of our previous special issue "Skin Microbiome, a Long Story of Clinical Trials".
The scientific community continues to demonstrate the functional role of the human gut and skin microbiome as an inspirational source for future therapeutics. Despite the huge potential offered by these discoveries in providing health in the long run, future therapeutics are still limited by the challenges in obtaining relevant clinical outcomes. In recent years, skin has evolved as one of the most extensively described tissue regarding microbiome diversities linked to host physiology, age, environmental exposure, and diseases. Moreover, the role of the skin microbiome has been validated by clinical results with respect to atopic dermatitis, psoriasis, acne, and seborrheic dermatitis.
This Special Issue gathers recent research and new results of the clinical evaluation of skin microbiome-based treatments. It will serve as guidance for scientists from the biopharmaceutical and academic community to investigate the causal role of the skin microbiota in disease and to create a new generation of microbiome-targeted therapeutics with predictable modes of action and consistent clinical outcomes.
Dr. Lionel Breton
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
